RECRUITING

AIMS Cancer Outcomes Study

Description

The overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year overall survival (OS) outcomes in advanced stage cancer patients receiving Advanced Integrative Oncology (AIO) treatment in a prospective consecutive case series outcomes study. We will collect data and study outcomes for patients with cancer who receive care at AIMS Institute.

Conditions

NeoplasmsNeoplasm MalignantAdvanced CancerAdvanced Solid TumorOncology
Talk to us

Related Conditions:

NeoplasmsNeoplasm MalignantAdvanced CancerAdvanced Solid TumorOncology

Study Overview

On this page

Study Details

Study overview

The overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year overall survival (OS) outcomes in advanced stage cancer patients receiving Advanced Integrative Oncology (AIO) treatment in a prospective consecutive case series outcomes study. We will collect data and study outcomes for patients with cancer who receive care at AIMS Institute.

Advanced Integrative Oncology Treatment for Adult and Pediatric Patients With Cancer: A Prospective Outcomes Study

AIMS Cancer Outcomes Study

Condition
Neoplasms
Intervention / Treatment

-

Contacts and Locations

Seattle

AIMS Institute, Seattle, Washington, United States, 98102

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. A new patient coming in for a first office call (FOC) or first consultation via telemedicine with a diagnosis of cancer, or
  • 2. An established patient with a diagnosis of cancer receiving treatment at the AIMS Institute;
  • 3. If over 18 years of age are able to understand study design adequately and provide signed informed consent (IC) to enrollment;
  • 4. If younger than 18 years of age informed assent from the child and informed consent from a parent or guardian who is able to understand the study design adequately and provide signed informed consent for the pediatric patient;
  • 5. A confirmed diagnosis of cancer based on medical oncology medical records.
  • 1. Patients not diagnosed with cancer;
  • 2. Telehealth patients;
  • 3. Cannot read or understand English well enough to read and sign the consent form and complete the questionnaires;
  • 4. Unwilling to participate in the AIMS Institute observational study.

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Advanced Integrative Medical Science Institute,

Study Record Dates

2030-12-31